Trayanova Lab’s and JHMI Digital Twin Research Featured in Wall Street Journal On March 16th, the Wall Street Journal featured Dr. Trayanova and her lab’s work with JHMI on “digital twins” of people’s hearts– a method of creating a patient-specific model to study electrical problems and potentially guide therapy in a clinical environment. Read more…
The three awards will enable ADVANCE researchers to develop deep learning learning methods to understand the recurrence of atrial fibrillation following catheter ablation, artificial intelligence to predict the risk of sudden death in Sarcoidosis, and computational approaches for arrhythmia risk prediction in Arrhythmogenic Right Ventricular Cardiomyopathy. Principal investigator Dr. Natalia Read more…
Hugh Calkins (Johns Hopkins Medical Institutions, Baltimore, USA) told delegates attending the AF Symposium 2020 (23–25 January, Washington, DC, USA) that cryoablation with the Arctic Front catheter (Medtronic) was a safe and effective approach for managing persistent atrial fibrillation (AF). He added that the procedure also improves quality of life and reduces symptoms.
In proof-of-concept study of 10 patients with atrial fibrillation, personalized models accurately predict where surgeons should destroy diseased heart tissue.
Members of the Alliance for Cardiovascular Diagnostic and Treatment Innovation (ADVANCE) and key Johns Hopkins leadership gathered to celebrate the launch of ADVANCE, the new interdisciplinary research center between the Whiting School of Engineering and the Department of Medicine that is posited to revolutionize the diagnosis and treatment of cardiovascular Read more…
In a new $5.5 million center that spans engineering and cardiology specialties at Johns Hopkins, experts aim to improve the diagnosis and treatment of heart rhythm disorders that affect millions of people by leveraging innovations in cardiac imaging, computer simulations and data science. The new center, called the Alliance for Cardiovascular Read more…
Drs. Trayanova and Calkins received a $3.15 million grant from NIH grant to develop improved ablation targeting strategies for ablation of persistent atrial fibrillation in patients with fibrotic remodeling.